Skip to main content
. 2021 Jul 29;6:93. Originally published 2021 Apr 29. [Version 2] doi: 10.12688/wellcomeopenres.16594.2

Figure 1. Trial schematic.

Figure 1.

Note: DAA: direct-acting antivirals. The ribavirin randomisation was a partial factorial in those randomised to a shorter course than the full licensed duration of therapy (the vast majority of participants recruited to the trial).